KR970703131A - 소수성 활성물질과 발포제를 포함하는 제약학적 조성물과 이의 준비공정(pharmaceutical preparation with a hydrophobic active substance and an effer vescent system, and process for preparing said preparation) - Google Patents
소수성 활성물질과 발포제를 포함하는 제약학적 조성물과 이의 준비공정(pharmaceutical preparation with a hydrophobic active substance and an effer vescent system, and process for preparing said preparation)Info
- Publication number
- KR970703131A KR970703131A KR1019960706945A KR19960706945A KR970703131A KR 970703131 A KR970703131 A KR 970703131A KR 1019960706945 A KR1019960706945 A KR 1019960706945A KR 19960706945 A KR19960706945 A KR 19960706945A KR 970703131 A KR970703131 A KR 970703131A
- Authority
- KR
- South Korea
- Prior art keywords
- preparation
- hydrophobic active
- active substance
- pct
- vescent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1890/94.0 | 1994-06-15 | ||
CH01890/94A CH686865A5 (de) | 1994-06-15 | 1994-06-15 | Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung. |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970703131A true KR970703131A (ko) | 1997-07-03 |
KR100367302B1 KR100367302B1 (ko) | 2003-04-16 |
Family
ID=4221002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960706945A KR100367302B1 (ko) | 1994-06-15 | 1995-05-19 | 소수성활성물질과발포제를포함하는제약학적조성물과이의준비공정 |
Country Status (26)
Country | Link |
---|---|
US (1) | US5834019A (ko) |
EP (1) | EP0768868B1 (ko) |
JP (1) | JPH10501535A (ko) |
KR (1) | KR100367302B1 (ko) |
CN (1) | CN1149071C (ko) |
AT (1) | ATE204744T1 (ko) |
AU (1) | AU684966B2 (ko) |
BR (1) | BR9508002A (ko) |
CA (1) | CA2191302C (ko) |
CH (1) | CH686865A5 (ko) |
CO (1) | CO4410175A1 (ko) |
CZ (1) | CZ287807B6 (ko) |
DE (1) | DE59509566D1 (ko) |
ES (1) | ES2161901T3 (ko) |
HU (1) | HU221680B1 (ko) |
IL (1) | IL114144A (ko) |
MX (1) | MX9606391A (ko) |
MY (1) | MY113718A (ko) |
NO (1) | NO314016B1 (ko) |
NZ (1) | NZ288208A (ko) |
PE (1) | PE42295A1 (ko) |
PL (1) | PL180135B1 (ko) |
SK (1) | SK281262B6 (ko) |
TW (1) | TW457097B (ko) |
WO (1) | WO1995034284A1 (ko) |
ZA (1) | ZA954932B (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69713948D1 (de) * | 1996-04-23 | 2002-08-22 | Janssen Pharmaceutica Nv | Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid |
EP0803251B1 (en) * | 1996-04-23 | 2002-07-17 | Janssen Pharmaceutica N.V. | Immediate release pH-independent solid dosage form of cisapride |
KR20010012104A (ko) * | 1997-06-11 | 2001-02-15 | 디르크 반테 | (+)- 또는 (-)-시사프라이드의 즉시 방출 pH-비의존적 고체 제형 |
WO2002085337A1 (en) | 2001-04-20 | 2002-10-31 | The University Of British Columbia | Micellar drug delivery systems for hydrophobic drugs |
US6589555B2 (en) | 1999-12-29 | 2003-07-08 | Mahendra Pandya | Effervescent vitaceutical compositions and related methods |
WO2002036077A2 (en) * | 2000-11-06 | 2002-05-10 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
CA2440935A1 (en) * | 2001-03-13 | 2002-09-19 | Richard Liggins | Micellar drug delivery vehicles and precursors thereto and uses thereof |
US20030157170A1 (en) * | 2001-03-13 | 2003-08-21 | Richard Liggins | Micellar drug delivery vehicles and precursors thereto and uses thereof |
JP2005506990A (ja) * | 2001-10-19 | 2005-03-10 | アイソテクニカ インコーポレーテッド | 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート |
US8092831B2 (en) * | 2002-11-08 | 2012-01-10 | Andrx Pharmaceuticals, Llc | Antihistamine and decongestant system |
US20050069590A1 (en) * | 2003-09-30 | 2005-03-31 | Buehler Gail K. | Stable suspensions for medicinal dosages |
CN100381123C (zh) * | 2005-01-12 | 2008-04-16 | 南京亿华药业有限公司 | 一种氯雷他定颗粒剂及其制法 |
CN101897732B (zh) * | 2009-05-27 | 2013-01-30 | 北京因科瑞斯医药科技有限公司 | 一种中药泡腾片剂及其制备方法 |
CN106236713B (zh) * | 2016-08-30 | 2018-11-09 | 林州中农颖泰生物肽有限公司 | 一种七清败毒泡腾颗粒及其制备方法 |
CN107296800A (zh) * | 2017-06-01 | 2017-10-27 | 江苏黄河药业股份有限公司 | 一种氯雷他定泡腾片及其制备方法 |
CN112741841A (zh) * | 2019-10-29 | 2021-05-04 | 湖北真奥医药研究院有限公司 | 三维钙自乳化泡腾剂组合物及其制剂的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3584522D1 (de) * | 1984-12-14 | 1991-11-28 | Gergely Gerhard | Teilchen aus einer hydrophoben oder schwerloeslichen substanz und verfahren zu ihrer hydrophilisierung. |
GB8528195D0 (en) * | 1985-11-15 | 1985-12-18 | Boots Co Plc | Therapeutic compositions |
GB9224021D0 (en) * | 1992-11-16 | 1993-01-06 | Boots Co Plc | Effervescent compositions |
US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
-
1994
- 1994-06-15 CH CH01890/94A patent/CH686865A5/de not_active IP Right Cessation
-
1995
- 1995-05-19 JP JP8501534A patent/JPH10501535A/ja not_active Ceased
- 1995-05-19 BR BR9508002-3A patent/BR9508002A/pt active Search and Examination
- 1995-05-19 AU AU27497/95A patent/AU684966B2/en not_active Ceased
- 1995-05-19 WO PCT/EP1995/001904 patent/WO1995034284A1/de active IP Right Grant
- 1995-05-19 CN CNB95193578XA patent/CN1149071C/zh not_active Expired - Fee Related
- 1995-05-19 CA CA2191302A patent/CA2191302C/en not_active Expired - Fee Related
- 1995-05-19 MX MX9606391A patent/MX9606391A/es not_active IP Right Cessation
- 1995-05-19 US US08/737,580 patent/US5834019A/en not_active Expired - Lifetime
- 1995-05-19 SK SK1593-96A patent/SK281262B6/sk unknown
- 1995-05-19 DE DE59509566T patent/DE59509566D1/de not_active Expired - Lifetime
- 1995-05-19 AT AT95922463T patent/ATE204744T1/de active
- 1995-05-19 ES ES95922463T patent/ES2161901T3/es not_active Expired - Lifetime
- 1995-05-19 NZ NZ288208A patent/NZ288208A/en unknown
- 1995-05-19 KR KR1019960706945A patent/KR100367302B1/ko not_active IP Right Cessation
- 1995-05-19 HU HU9603452A patent/HU221680B1/hu not_active IP Right Cessation
- 1995-05-19 PL PL95317856A patent/PL180135B1/pl unknown
- 1995-05-19 EP EP95922463A patent/EP0768868B1/de not_active Expired - Lifetime
- 1995-05-19 CZ CZ19963672A patent/CZ287807B6/cs not_active IP Right Cessation
- 1995-06-14 IL IL11414495A patent/IL114144A/xx not_active IP Right Cessation
- 1995-06-14 ZA ZA954932A patent/ZA954932B/xx unknown
- 1995-06-14 PE PE1995271312A patent/PE42295A1/es not_active Application Discontinuation
- 1995-06-14 CO CO95026284A patent/CO4410175A1/es unknown
- 1995-06-15 MY MYPI95001623A patent/MY113718A/en unknown
- 1995-06-15 TW TW084106115A patent/TW457097B/zh not_active IP Right Cessation
-
1996
- 1996-12-09 NO NO19965244A patent/NO314016B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970703131A (ko) | 소수성 활성물질과 발포제를 포함하는 제약학적 조성물과 이의 준비공정(pharmaceutical preparation with a hydrophobic active substance and an effer vescent system, and process for preparing said preparation) | |
PT760649E (pt) | Formulacoes a base de propionato de fluticasona | |
ES2154737T3 (es) | Proceso para preparar formas de dosificacion farmaceutica solidas de substancias hidrofobicas. | |
DE59602775D1 (de) | 6-Dimethylaminomethyl-1-phenyl-cyclo-hexanverbindungen als pharmazeutische Wirkstoffe | |
DE59604226D1 (de) | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-olverbindungen als pharmazeutische Wirkstoffe | |
EE200100660A (et) | Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake | |
AU5022593A (en) | Prodrugs, their preparation and use as pharmaceuticals | |
IT1246188B (it) | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. | |
AU5651696A (en) | Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them | |
FR2771291B1 (fr) | Spheroides, procede de preparation et compositions pharmaceutiques | |
ES2178154T3 (es) | Proceso de preparacion de formas solidas de dosificacion farmaceutica. | |
HUT55403A (en) | Process for producing modified gangliosides and their functional derivatives, as well as pharmaceutical compositions comprising such active ingredient | |
BR9806280A (pt) | Grânulos compreendendo clavulaneto e um ou mais excipientes | |
FR2771292B1 (fr) | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques | |
NO910874D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater. | |
BR9404225A (pt) | Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações | |
RU94040150A (ru) | Стабильная лиофилизированная композиция тиотепа, способ ее получения | |
SE8302580D0 (sv) | Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning | |
BR9508021A (pt) | Composição farmacêutica para o tratamento de distúrbios esquizofrênicos, uso de um agente imunossupressor, e, processo de tratamento de um paciente esquizofrênico | |
MX9305997A (es) | 6-heterociclic-4-amino-1, 2, 2a, 3, 4, 5-hexahidrobenz[cd]indoles yprocedimiento para su preparacion. | |
AU2506188A (en) | Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance | |
IT1254938B (it) | Derivati otticamente attivi della n-imminoalchil-n'-((2-idrossi- 2-fenil-2-cicloesil)-etil)-piperazina | |
ITMI930273A0 (it) | Composti terapeuticamente attivi, utili per il trattamento di malattie connesse con alterata funzionalita' del sistema immunitario procedimento per la loro preparazione e composizione farmaceutiche che li contengono | |
NO307460B1 (no) | Optiske aktive forbindelser, fremgangsmõte for fremstilling derav, farmasøytisk blanding og anvendelse derav | |
ITMI951011A0 (it) | Apparecchio per la preparazione di preparati cromosomici |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |